Turn Therapeutics Inc.
TTRX
$3.98
$0.102.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 114.66% | -142.73% | 0.00% | -142.80% | 51.52% |
| Total Depreciation and Amortization | 3.65% | 9.60% | 0.00% | 0.81% | 2.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5,689.09% | -78.96% | 0.00% | 287.78% | -80.57% |
| Change in Net Operating Assets | -41.97% | 579.86% | 0.00% | 210.47% | -671.77% |
| Cash from Operations | -99.85% | -47.52% | 0.00% | 7.32% | -14.40% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 65.03% | -464.78% | 0.00% | -103.85% | 82.07% |
| Cash from Investing | 65.03% | -464.78% | 0.00% | -103.85% | 82.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 434.43% | -62.21% | 0.00% | 201.34% | 61.42% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 434.43% | -62.21% | 0.00% | 201.34% | 61.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,450.84% | -107.23% | 0.00% | 1,282.70% | 187.11% |